What is the appropriate management of ulcerogenic pylorostenosis?

Management of Ulcerogenic Pylorostenosis

Ulcerogenic pylorostenosis requires initial endoscopic dilation or surgical intervention (truncal vagotomy with antrectomy or pyloroplasty), followed by mandatory H. pylori eradication therapy and prolonged PPI treatment until complete healing is confirmed. 1, 2

Initial Management Approach

Surgical vs. Conservative Decision

For decompensated pylorostenosis (inability to tolerate oral intake, severe malnutrition, or failed conservative management):

• Truncal vagotomy with antrectomy is the most effective definitive procedure with <1% ulcer recurrence 3
• Vagotomy with pyloroplasty is an acceptable alternative for higher-risk patients 2, 3

For compensated stenosis (able to tolerate some oral intake):

• Attempt endoscopic balloon dilation
• Initiate aggressive medical therapy with high-dose PPI
• Reserve surgery for treatment failures 2

Critical caveat: Simple pyloroplasty alone without addressing the underlying ulcer disease leads to high recurrence rates and should be avoided unless combined with definitive ulcer therapy 2.

Post-Intervention Medical Management

H. pylori Eradication (Mandatory)

Surgery does not eliminate H. pylori infection - over 80% of patients remain infected post-operatively, leading to ulcer recurrence and chronic gastritis of the operated stomach 2. Therefore:

1. Test all patients for H. pylori using rapid urease test or serology
2. Initiate eradication therapy as soon as oral feeding resumes 1
3. First-line regimen: Bismuth quadruple therapy for 14 days (bismuth + tetracycline + metronidazole + PPI) 1, 4
4. Confirm eradication at 4 weeks post-treatment using urea breath test (UBT) or monoclonal stool antigen test 1

Acid Suppression Strategy

Prolonged PPI therapy is mandatory for complicated ulcers with stenosis 1:

• Continue PPI until complete healing is endoscopically confirmed 1
• This typically requires 8-12 weeks for gastric ulcers and complicated duodenal ulcers 5, 6
• Do NOT discontinue PPI after H. pylori eradication in stenotic ulcers (unlike uncomplicated duodenal ulcers) 1

Endoscopic Follow-up

Mandatory endoscopic surveillance is required 1:

• Repeat endoscopy to document complete ulcer healing
• Confirm resolution of stenosis
• Obtain biopsies to verify H. pylori eradication if UBT unavailable
• Rule out malignancy (gastric ulcers can harbor cancer)

Management of Concomitant Risk Factors

NSAID/Aspirin Management

If NSAIDs or aspirin contributed to stenosis 5, 6:

• Discontinue NSAIDs if possible (heals 95% of ulcers and reduces recurrence from 40% to 9%) 6
• If continuation necessary: Switch to selective COX-2 inhibitor + continue PPI 5
• For aspirin: Continue PPI indefinitely for secondary prevention 5

Idiopathic Cases

In H. pylori-negative, NSAID-negative patients (22% of cases) 7:

• Investigate for chronic liver disease (associated with idiopathic PUD) 7
• Screen for other ulcerogenic medications (corticosteroids, anticoagulants)
• Continue long-term PPI therapy

Prevention of Recurrence

The combination of H. pylori eradication + addressing NSAID use reduces ulcer recurrence from 50-60% to 0-2% 6. Specifically:

• H. pylori eradication alone: Reduces recurrence to 0-2% 6
• NSAID discontinuation alone: Reduces recurrence to 9% 6
• Combined approach: Near-zero recurrence 6

Common pitfall: Failing to eradicate H. pylori post-operatively leads to ulcer recurrence, chronic gastritis, and progression to atrophic gastritis with increased cancer risk 2. This is preventable with systematic post-operative H. pylori testing and treatment.

Algorithm Summary

1. Assess severity → Decompensated = surgery; Compensated = trial of dilation + medical therapy
2. Surgical choice → Vagotomy-antrectomy (best) or vagotomy-pyloroplasty (higher risk patients)
3. Immediate post-op → Test for H. pylori when oral feeding resumes
4. Eradication → Bismuth quadruple therapy × 14 days
5. Acid suppression → Continue PPI until endoscopic healing confirmed (8-12 weeks)
6. Confirm cure → UBT at 4 weeks post-eradication
7. Endoscopic follow-up → Document complete healing and rule out malignancy
8. Address NSAIDs → Discontinue or switch to COX-2 + maintain PPI

This systematic approach addresses both the mechanical obstruction and the underlying ulcer disease, preventing the 50-60% recurrence rate seen with incomplete management 6.